Scientists make strides in creation of clinical-grade bone

ScienceDaily | 1/15/2019 | Staff
n.king (Posted by) Level 3
Click For Photo: https://www.sciencedaily.com/images/2019/01/190115162331_1_540x360.jpg

"NYSCF is committed to bringing effective cellular therapies to patients in need," says NYSCF CEO Susan L. Solomon. "To establish these therapies, it is essential to produce high-quality cells that meet safety requirements for clinical use, which is a step that this research is helping us achieve."

MP cells are important because they resemble mesenchymal stem cells (MSCs). MSCs can go on to form a variety of cell types, including bone cells, cartilage cells, muscle cells, and fat cells, and can modulate the behavior of many other types of cell types in the body. They are a frequent target for cell therapies in which healthy cells are introduced into the body to treat diseases or reconstruct tissues and organs. However, MSCs are often scarce and do not expand well enough to provide the amount of cells needed for an effective therapy. MP cells, on the other hand, can be produced in large numbers for each patient when generated from induced pluripotent stem cells (iPSCs), and therefore hold extraordinary promise for the treatment of blood, heart, and immune diseases as well as repair of damaged bone and cartilage.

MP - Cells

"MP cells have been derived from...
(Excerpt) Read more at: ScienceDaily
Wake Up To Breaking News!
Sign In or Register to comment.

Welcome to Long Room!

Where The World Finds Its News!